89. M. A. Hamburg, "FDA Supports Development of Innovative Genetic Tests," Wall Street Journal, December 3, 2013: http://online.wsj.com/news/articles/ SB10001424052702304011304579222111609444156.

90. F. S. Collins and M. A. Hamburg, "First FDA Authorization for Next-Generation Sequencer," New England Journal of Medicine 369 (2013): 2369–2371.

91. "Regulation of Laboratory Developed Tests (LDTs)," American Society for Clinical Pathology, 2010, http://www.ascp.org/PDF/Advocacy/Regulation-of-laboratory-developed-tests-LDTs.aspx.

92. P. Offt, Do You Believe in Magic? (New York, NY: HarperCollins, 2013).

93. A. O'Connor, "Spike in Harm to Liver Is Tied to Dietary Aids," New York Times, December 22, 2013, http://www.nytimes.com/2013/12/22/us/spike-in-harm-to-liver-is-tied-to-dietary-aids.html.

94. J. Pickrell, "Should the FDA Regulate the Interpretation of Traditional Epidemiology?" Genomes Unzipped, February 12, 2013, http://www.genomesunzipped.org/2013/12/should-the-fda-regulate-the-interpretation-of-traditional-epidemiology.php.

95. D. Dobbs, "Is the National Cancer Institute Telling Me to Remove My Breasts?" Neuron Culture, December 2, 2013, http://daviddobbs.net/smoothpebbles/is-the-national-cancer-institute-telling-me-to-remove-my-breasts/.

96. M. Eisen, "FDA vs. 23andMe: How Do We Want Genetic Testing to Be Regulated?" it is NOT junk, November 26, 2013, http://www.michaeleisen.org/blog/?p=1480.

97. "The FDA and me," Nature 504 (2013): 7–8.

98. C. Seife, "23andMe Is Terrifying, but Not for the Reasons the FDA Thinks," Scientific American, November 27, 2013, http://www.scientificamerican.com/article.cfm?id=73505andme-is-terrifying-but-not-for-reasons-fda.

99. A. R. Venkitaraman, "Cancer Suppression by the Chromosome Custodians, BRCA1 and BRCA2," Science 343 (2014): 1470–1475.

100. D. B. Agus, "The Outrageous Cost of a Gene Test," New York Times, May 21, 2013, http://www.nytimes.com/2013/05/21/opinion/the-outrageous-cost-of-a-gene-test.html.

101. Supreme Court of the United States, "Association for Molecular Pathology et al. versus Myriad Genetics, Inc., et al." SCOTUS, 2013, http://www.supremecourt.gov/opinions/12pdf/12-398_1b7d.pdf.

102. M. Specter, "Can We Patent Life?" New Yorker, April 1, 2013, http://www.newyorker.com/online/blogs/elements/2013/04/myriad-genetics-patent-genes.html.

103. E. Marshall, "Supreme Court Rules Out Patents on 'Natural' Genes," Science 340 (2013): 1387–1388.

104. N. Feldman, "The Supreme Court's Bad Science on Gene Patents," Bloomberg View, June 13, 2013, http://www.bloombergview.com/articles/2013-06-13/the-supreme-court-s-bad-science-on-gene-patents.

105. R. Cook-Deegan, "Are Human Genes Patentable?" Annals of Internal Medicine 159, no. 4 (2013): 298–299.

106. N. Totenberg, "Supreme Court Asks: Can Human Genes Be Patented?" NPR Shots, April 15, 2013, http://www.npr.org/blogs/health/2013/04/15/177035299/supreme-court-asks-can-human-genes-be-patented.

107. E. J. Topol, "DNA & Supreme Court: Nature Cannot Be Patented," Union-Tribune San Diego, April 27, 2013, http://www.utsandiego.com/news/2013/apr/27/dna-supreme-court-nature-cannot-be-patented/.

108. J. Guo, "The Supreme Court Reveals Its Ignorance of Genetics," New Republic, June 13, 2013, http://www.newrepublic.com//article/113476/supreme-court-genetics-ruling-reveals-judges-ignorance.

109. D. J. Kevles, "Can They Patent Your Genes?" New York Review of Books, March 7, 2013, http://www.nybooks.com/articles/archives/2013/mar/07/can-they-patent-your-genes/.

110. C. Y. Johnson, "Eric Lander Weighs In on Gene Patenting Case," Boston Globe, February 26, 2013, http://www.bostonglobe.com/lifestyle/health-wellness/2013/02/26/eric-lander-human-genome-project-leader-weighs-supreme-court-gene-patenting-case/EjRae5IRYwUYRVLg6NXTZL/story.html.

111. L. O. Gostin, "Who Owns Human Genes? Is DNA Patentable?" Journal of the American Medical Association 310, no. 8 (2013): 791–792.

112. G. Mohan, "Researchers Hail Supreme Court Decision on Gene Patent," Los Angeles Times, June 13, 2013, http://www.latimes.com/news/science/sciencenow/la-sci-sn-gene-patent-reaction-20130613,0,6362625,print.story.

113. H. Ledford, "Myriad Ruling Causes Confusion," Nature 498 (2013): 281–282.

114. S. Reardon, "I Discovered the BRCA Genes," Slate, June 15, 2013, http://www.slate.com/articles/health_and_science/ new_scientist/2013/06/brca_gene_discovery_mary_ claire_king_says_the_supreme_court_is_right_not.html.

115. J. Carlson, "Myriad Stock Falls as Competitors Offer Lower Prices for Gene Testing," Modern Healthcare, June 13, 2013, http://www.modernhealthcare.com/article/20130613/NEWS/306139947/.

116. J. Walker, "Reimbursement for Breast-Cancer Risk Test to Be Cut," Wall Street Journal, December 29, 2013, http://online.wsj.com/news/article_email/ SB10001424052702304361604579288591617575358 -lMyQjAxMTA0MDIwOTEyNDkyWj.

117. C. Gunter, "SCOTUS Ruling Means Cheaper Genetic Testing," Double X Science, June 14, 2013, http://www.doublexscience.org/myriad-genetics-ruling/.

118. J. Carlson, "'The Cost Will Drop,'" Modern Healthcare, June 15, 2013, http://www.modernhealthcare.com/article/ 20130615/MAGAZINE/306159974/.

119. M. Scudellari, "Myriad Sues Developers of Competing Breast Cancer Tests," Nature Medicine 19, no. 8 (2013): 948.

120. R. Nussbaum, "Free Our Genetic Data," MIT Technology Review, July 25, 2013, http://www.technologyreview.com/view/517526/free-our-genetic-data/.

121. "Life on Mars? Discover Magazine Announces the Top 100 Stories of 2013," Discover, Jan – Feb 2014, http://discovermagazine.com/2014/jan-feb.

1. A. Pentland, «How Big Data Can Transform Society for the Better,» Scientific American, October 1, 2014, http://www.scientificamerican.com/article/how-big-data-can-transform-society-for-the-better/.

2. S. Lohr, "Sizing Up Big Data, Broadening Beyond the Internet," New York Times, June 19, 2013, http://bits.blogs.nytimes.com/2013/06/19/sizing-up-big-data-broadening-beyond-the-internet/.

3. "Epidemiolog y," Wikipedia, accessed August 13, 2014, 2014, http://en.wikipedia.org/wiki/Epidemiology.

4. J. L. Gardy et al., "Whole-Genome Sequencing and Social-Network Analysis of a Tuberculosis Outbreak," The New England Journal of Medicine 364 (2011): 730–739.

5. E. Topol, "Individualized Medicine from Prewomb to Tomb," Cell 157 (2014): 241–253.